4,552 publications from this institution
Abstract Several alkoxy‐5‐nitrosopyrimidines were synthesised and high regioselective and sequential nucleophilic aromatic substitution of methoxy groups in 2‐amino‐4,6‐dimethoxy‐5‐nitrosopyrimidine was observed. The approach was applied to the synthesis of valuable polyfunctionalised aminopyrimidines capable of mimicking fused heterobicyclic derivatives of biological interest. In addition, new compounds were evaluated as antivirals and their usefulness as synthetic intermediates was demonstrated.
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTStructure investigation and anti-HIV activities of high-molecular weight ATA polymersMark Cushman, Pinglang Wang, Dominique Schols, Erik De Clercq, and Joseph G. StowellCite this: J. Org. Chem. 1992, 57, 26, 7241–7248Publication Date (Print):December 1, 1992Publication History Published online1 May 2002Published inissue 1 December 1992https://pubs.acs.org/doi/10.1021/jo00052a045https://doi.org/10.1021/jo00052a045research-articleACS PublicationsRequest reuse permissionsArticle Views182Altmetric-Citations19LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information Get e-Alerts
5-(2-Chloroethyl)-2'-deoxyuridine (CEDU), 5-(3-chloropropyl)-2'-deoxyuridine (CPDU), and 5-(2-chloroethyl)-2'-deoxycytidine (CEDC) were evaluated for activity against herpes simplex virus type 1 (HSV-1) and HSV-2 in vitro. Their MICs for HSV-1 in primary rabbit kidney cell cultures were 0.15, 0.20, and 0.60 micrograms/ml, respectively; their MICs for HSV-2 were about 10-fold higher. When tested in parallel, the reference compounds 5-ethyl-2'-deoxyuridine, 5-iodo-2'-deoxyuridine, acyclovir, and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) gave MICs of 0.20, 0.18, 0.04, and 0.015 micrograms/ml, respectively. The antiviral indexes of CEDU, CPDU, and CEDC, as determined by the ratio of the minimum toxic dose for the normal host cell to the minimum inhibitory dose for HSV-1, were about 2,000, 100, and greater than or equal to 400, respectively. The three 5-(2-haloalkyl)pyrimidine derivatives were further evaluated for their antiviral effects in vivo. In hairless mice, CEDU suppressed the development of cutaneous HSV-1 lesions, and associated mortality, when applied topically at a concentration as low as 0.1%. For the treatment of systemic HSV-1 infection in Naval Medical Research Institute mice, a single oral dose per day of 5 mg of CEDU per kg achieved a significant reduction in the mortality rate. Against HSV-1 encephalitis, CEDU exerted a significant protective effect at a dosage of 50 mg/kg per day when administered intraperitoneally. CEDU was effective against systemic HSV-1 infection and HSV-1 encephalitis in mice at a 5- to 15-fold-lower dose than either BVDU or acyclovir. When given orally, CPDU and CEDC were considerably less active than CEDU against systemic HSV-1 infection.
Human cytomegalovirus (HCMV) infections are a major cause of mortality and morbidity in human transplant recipients and a serious problem in patients with AIDS. Furthermore, CMV is the most frequent viral cause of congenital abnormalities. Two drugs are currently licensed for the treatment of severe CMV infections, i.e. ganciclovir (Cymevene) and foscarnet (Foscavir). However, both compounds may give severe side-effects, and resistant strains may emerge during long-term therapy. Therefore, the development of new and more effective anti-CMV drugs is one of the top priorities in current antiviral drug research. The first goal of our study was to devise an assay for the rapid and automated screening of large series of compounds against CMV. The new method that we present is based on the enhanced esterase activity in the CMV-infected cell. The method significantly reduces labor time as compared to the microscopical method that is currently used. Secondly, we investigated the anti-CMV activity of the acyclic nucleoside phosphonate (ANP) analogue HPMPC [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. HPMPC was recently identified in our laboratory as the most potent and selective anti-CMV compound described so far. We found that HPMPC specifically inhibits viral DNA synthesis and that the compound is endowed with an unique long-lasting antiviral effect. We then compared the antiviral potencies of HPMPC and ganciclovir in murine models for murine CMV (MCMV) infections. As could be expected from our in vitro data, HPMPC was far superior over ganciclovir in preventing MCMV-induced mortality. In order to mimic more closely the HCMV disease progression in immunocompromised patients, we elaborated a model for MCMV infections in mice with severe combined immune deficiency (SCID). The anti-CMV activity of HPMPC and DHPS was compared in several clinical relevant treatment schedules in the SCIO mouse model. HPMPC appeared in all conditions to be much more effective than ganciclovir. We also found that PMEDAP [9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine], an ANP with potent antiretroviral activity, is highly efficacious in the treatment of MCMV-associated mortality in both immunocompetent and immunodeficient (SCID) mice. Our third aim was to determine the mechanism by which polyanionic polymers [sulfated polymers, polycarboxylates and polyoxometalates] exhibit anti-HCMV activity. All these compounds were found to inhibit the adsorption of HCMV to the cells.(ABSTRACT TRUNCATED AT 400 WORDS)
Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.